3,962
Participants
Start Date
February 7, 2023
Primary Completion Date
January 15, 2025
Study Completion Date
January 15, 2025
RSVPreF3 vaccine
No intervention is administered in this extension study. Participants received the RSVPreF3 vaccine during the prior RSV MAT studies (RSV MAT-001, RSV MAT-004, RSV MAT-010, RSV MAT-011, RSV MAT-009, RSV MAT-012 and RSV MAT-039) according to the vaccination schedule specific to each study. In all prior RSV MAT studies, participants received one dose of RSVPreF3 vaccine except in RSV MAT-011 study, where some participants received a second dose as well.
Control
No intervention is administered in this extension study. Participants received any control (placebo, Tdap or influenza vaccine) during the prior RSV MAT studies (RSV MAT-001, RSV MAT-004, RSV MAT-010, RSV MAT-011, RSV MAT-009, RSV MAT-012 and RSV MAT-039) according to the vaccination schedule specific to each study. In all prior RSV MAT studies, participants received one dose of any control (placebo, Tdap or influenza vaccine).
GSK Investigational Site, Taoyuan District
GSK Investigational Site, Manila
GSK Investigational Site, Panama City
GSK Investigational Site, Manila
GSK Investigational Site, Grafton Auckland
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Papatoetoe Auckland
GSK Investigational Site, Soweto Gauteng
GSK Investigational Site, Johannesburg
GSK Investigational Site, Leuven
GSK Investigational Site, Sylhet
GSK Investigational Site, Clayton
GSK Investigational Site, South Brisbane
GSK Investigational Site, Southport
GSK Investigational Site, Córdoba
GSK Investigational Site, Wellington
GSK Investigational Site, Panama City
GSK Investigational Site, Ghent
GSK Investigational Site, Sint-Niklaas
GSK Investigational Site, Taipei
GSK Investigational Site, Bangkok
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Milan
GSK Investigational Site, Turku
GSK Investigational Site, San Pedro Sula
GSK Investigational Site, Hamburg
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Aravaca
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Pori
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Boadilla Del Monte Madrid
GSK Investigational Site, TorrejOn Ardoz Madrid
GSK Investigational Site, Getafe
GSK Investigational Site, Málaga
GSK Investigational Site, Marbella
GSK Investigational Site, Greenville
GSK Investigational Site, Hendersonville
GSK Investigational Site, Hanover
GSK Investigational Site, Bordeaux
GSK Investigational Site, Tampere
GSK Investigational Site, Mobile
GSK Investigational Site, Biloxi
GSK Investigational Site, Taichung
GSK Investigational Site, Seville
GSK Investigational Site, Seville
GSK Investigational Site, Englewood
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Valladolid
GSK Investigational Site, Goch
GSK Investigational Site, Bilbao
GSK Investigational Site, Detroit
GSK Investigational Site, Saginaw
GSK Investigational Site, Chiang Mai
GSK Investigational Site, Mainz
GSK Investigational Site, Prato
GSK Investigational Site, Seinäjoki
GSK Investigational Site, Kokkola
GSK Investigational Site, Norfolk
GSK Investigational Site, Bron
GSK Investigational Site, Bari
GSK Investigational Site, Covington
GSK Investigational Site, Slidell
GSK Investigational Site, Plano
GSK Investigational Site, Paris
GSK Investigational Site, Keller
GSK Investigational Site, Keller
GSK Investigational Site, Keller
GSK Investigational Site, Weatherford
GSK Investigational Site, Fort Worth
GSK Investigational Site, Lampasas
GSK Investigational Site, Houston
GSK Investigational Site, Austin
GSK Investigational Site, Nampa
GSK Investigational Site, Nampa
GSK Investigational Site, Phoenix
GSK Investigational Site, Tucson
GSK Investigational Site, Albuquerque
GSK Investigational Site, Los Angeles
GSK Investigational Site, Oulu
GSK Investigational Site, Burbank
GSK Investigational Site, Würzburg
GSK Investigational Site, Seattle
GSK Investigational Site, Messina
GSK Investigational Site, Chía
GSK Investigational Site, Pune
GSK Investigational Site, Vadu Budruk Pune
GSK Investigational Site, Nagpur
GSK Investigational Site, Mysore
GSK Investigational Site, Mangalore
GSK Investigational Site, Kolkata
GSK Investigational Site, Barranquilla
GSK Investigational Site, Cali Colombia
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Matlab
GSK Investigational Site, Santo Domingo Este
GSK Investigational Site, Comayagua
GSK Investigational Site, Seoul
GSK Investigational Site, Nova Iguaçu
GSK Investigational Site, RibeirAo PretoSP
GSK Investigational Site, Santa Maria
GSK Investigational Site, São José do Rio Preto
GSK Investigational Site, Surrey
GSK Investigational Site, Vancouver
GSK Investigational Site, Halifax
GSK Investigational Site, Truro
GSK Investigational Site, Kingston
GSK Investigational Site, London-Ontario
GSK Investigational Site, Sarnia
GSK Investigational Site, Toronto
GSK Investigational Site, Joliette
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Medellín
GSK Investigational Site, Espoo
GSK Investigational Site, Helsinki
GSK Investigational Site, Helsinki
GSK Investigational Site, Helsinki
GSK Investigational Site, Järvenpää
GSK Investigational Site, Panama City
GSK Investigational Site, Panama City
GSK Investigational Site, Pretoria
GSK Investigational Site, Soshanguve
GSK Investigational Site, Ansan
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Burgos
GSK Investigational Site, Taipei
Lead Sponsor
GlaxoSmithKline
INDUSTRY